CLINICAL PHARMACOLOGICAL PERSPECTIVES OF ADJUVANT PROBIOTIC THERAPY IN ACNE VULGARIS: RESULTS OF A PILOT CULTURE-BASED STUDY OF THE INTESTINAL MICROBIOTA
Farmaciâ Kazahstana · 30.10.2026 · 21
DOI: 10.53511/pharmkaz.2026.5.2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Farmaciâ Kazahstana, online erschienen am 30.10.2026. Verfasst von Akmaral Dzhumabaeva und 1 weiteren Autor:innen. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Adjunctive probiotics in acne vulgaris are being considered in relation to the safety of systemic pharmacotherapy and the potential gut–skin interaction. Characterising the intestinal microbial profile may inform the design of future clinical pharmacology studies. However, culture-based observations alone cannot establish the efficacy or safety of a probiotic product.
Zitieren
APA
Dzhumabaeva, A., & Abuova, G. (2026). CLINICAL PHARMACOLOGICAL PERSPECTIVES OF ADJUVANT PROBIOTIC THERAPY IN ACNE VULGARIS: RESULTS OF A PILOT CULTURE-BASED STUDY OF THE INTESTINAL MICROBIOTA. Farmaciâ Kazahstana, 21. https://doi.org/10.53511/pharmkaz.2026.5.2
Vancouver
Dzhumabaeva A, Abuova G. CLINICAL PHARMACOLOGICAL PERSPECTIVES OF ADJUVANT PROBIOTIC THERAPY IN ACNE VULGARIS: RESULTS OF A PILOT CULTURE-BASED STUDY OF THE INTESTINAL MICROBIOTA. Farmaciâ Kazahstana. 2026:21. doi:10.53511/pharmkaz.2026.5.2
BibTeX
@article{Dzhumabaeva2026,
author = {Dzhumabaeva, Akmaral and Abuova, Gulzhan},
title = {CLINICAL PHARMACOLOGICAL PERSPECTIVES OF ADJUVANT PROBIOTIC THERAPY IN ACNE VULGARIS: RESULTS OF A PILOT CULTURE-BASED STUDY OF THE INTESTINAL MICROBIOTA},
journal = {Farmaciâ Kazahstana},
year = {2026},
pages = {21},
doi = {10.53511/pharmkaz.2026.5.2}
}
EUVIMED